LYZ and lung carcinoma: In this study, we postulated that FA-ExoPAC releases PAC inside the cancer cells either through direct release or by the lysozyme-mediated digestion, which was clearly demonstrated by its in vivo antitumor response against subcutaneous and orthotropic lung cancer xenografts.